European Union - English - EMA (European Medicines Agency)

intervet international bv - protein do (non-toxic deletion derivative of pasteurella multocida dermonecrotic toxin), inactivated bordetella bronchiseptica cells - immunologicals for suidae - pigs (gilts and sows) - for the reduction of clinical signs of progressive atrophic rhinitis in piglets by passive oral immunisation with colostrum from dams actively immunised with the vaccine.

European Union - English - EMA (European Medicines Agency)

intervet international bv - clostridium perfringens type c / escherichia coli f4ab / e. coli f4ac / e. coli f5 / e. coli f6 / e. coli lt - immunologicals - pigs - for the passive immunisation of progeny by active immunisation of sows and gilts to reduce mortality and clinical signs during the first days of life, caused by those escherichia coli strains which express the adhesins f4ab (k88ab), f4ac (k88ac), f5 (k99) or f6 (987p) and caused by clostridium perfringens type c.,

European Union - English - EMA (European Medicines Agency)

intervet international bv - porcine circovirus type 2 orf2 subunit antigen - immunologicals for suidae - pigs - for the active immunisation of pigs to reduce the virus load in blood and lymphoid tissues and to reduce weight loss associated with porcine-circovirus-type-2 infection occurring during the fattening period.onset of immunity: 2 weeksduration of immunity: 22 weeks

European Union - English - EMA (European Medicines Agency)

intervet international b.v. - porcine circovirus type 2 orf2 subunit antigen - immunologicals for suidae, inactivated viral vaccines - pigs - for the active immunisation of pigs to reduce viraemia, virus load in lungs and lymphoid tissues and virus shedding caused by pcv2 infection. to reduce loss of daily weight gain and mortality associated with pcv2 infection.

European Union - English - EMA (European Medicines Agency)

intervet international b.v. - porcine circovirus type 2 (pcv2) orf2 subunit antigen, mycoplasma hyopneumoniae j strain inactivated - immunologicals for suidae, inactivated viral and inactivated bacterial vaccines - pigs (for fattening) - for the active immunisation of pigs to reduce viraemia, virus load in lungs and lymphoid tissues, virus shedding caused by porcine circovirus type 2 (pcv2) infection, and severity of lung lesions caused by mycoplasma hyopneumoniae infection. to reduce the loss of daily weight gain during the finishing period in face of infections with mycoplasma hyopneumoniae and/or pcv2 (as observed in field studies)

European Union - English - EMA (European Medicines Agency)

intervet international bv - classical swine fever virus (csfv) -e2 subunit antigen - immunologicals for suidae - pigs - active immunisation of pigs from the age of 5 weeks onwards to prevent mortality and to reduce clinical signs of classical swine fever, as well as to reduce infection with and excretion of csf field virus.the onset of protection is 2 weeks.the duration of protection is 6 months.

European Union - English - EMA (European Medicines Agency)

intervet international bv - f4ab (k88ab) fimbrial adhesin, f4ac (k88ac) fimbrial adhesin, f5 (k99) fimbrial adhesin, f6 (987p) fimbrial adhesin, lt toxoid - immunologicals - pigs (gilts and sows) - for the passive immunisation of piglets by active immunisation of sows / gilts to reduce mortality and clinical signs such as diarrhoea due to neonatal enterotoxicosis during the first days of life, caused by those e.coli strains which express the fimbrial adhesins f4ab (k88ab), f4ac (k88ac), f5 (k99) or f6 (987p).

Ireland - English - HPRA (Health Products Regulatory Authority)

intervet ireland limited - concentrate of actinobacillus pleuropneumoniae antigens containing; omp (outer membrane protein); apxi (105 kilodalton type i toxoid); apxii (105 kilodalton type ii toxoid); apxiii (120 kilodalton macrophage toxoid) - suspension for injection - . - actinobacillus/haemophilus vaccine - pigs - immunological - inactivated vaccine

New Zealand - English - Ministry for Primary Industries

schering-plough animal health limited - mycoplasma hyopneumoniae; porcine circovirus type 2 orf-2 protein - mycoplasma hyopneumoniae 0 vaccine; porcine circovirus type 2 orf-2 protein 0 vaccine - vaccine

Ireland - English - HPRA (Health Products Regulatory Authority)

intervet ireland limited - erysipelothrix rhusiopathiae strain m2 (serotype 2) - suspension for injection - . - inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) - pigs - immunological - inactivated vaccine